Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

Myoview

×

Overview

What is Myoview?



What does Myoview look like?



What are the available doses of Myoview?

Kit for preparation injection: lyophilized powder containing 1.38 mg tetrofosmin in a multiple-dose vial after reconstitution with Tc99m eluate, clear solution not exceeding 2960 MBq/mL (80 mCi/mL).

What should I talk to my health care provider before I take Myoview?

How should I use Myoview?

Myocardial perfusion imaging under rest and/or exercise or pharmacologic stress conditions to delineate regions of reversible myocardial ischemia or infarcted myocardium in patients with known or suspected coronary artery disease.

Technetium Tc99m tetrofosmin is a radioactive drug and should be handled with appropriate safety measures to minimize radiation exposure during administration . Use waterproof gloves and effective shielding, including syringe shields, when preparing and administering technetium Tc99m tetrofosmin injection.


What interacts with Myoview?

Sorry No Records found


What are the warnings of Myoview?

Sorry No Records found


What are the precautions of Myoview?

Sorry No Records found


What are the side effects of Myoview?

Sorry No records found


What should I look out for while using Myoview?

None.


What might happen if I take too much Myoview?

Sorry No Records found


How should I store and handle Myoview?

Store the kit at 2°-8°C (36°-46°F). Protect the kit from light.This reagent kit is approved for use by persons under license by the Nuclear Regulatory Commission or the relevant regulatory authority of an Agreement State; store and dispose of technetium Tc99m tetrofosmin in accordance with these regulations.Store the kit at 2°-8°C (36°-46°F). Protect the kit from light.This reagent kit is approved for use by persons under license by the Nuclear Regulatory Commission or the relevant regulatory authority of an Agreement State; store and dispose of technetium Tc99m tetrofosmin in accordance with these regulations.Diflunisal tablets USP are supplied as follows:500 mg – light blue-purple, capsule-shaped, film-coated tablets, debossed “755/93” on one side, plain on other. Packaged in bottles of 10, 15, 20 and 30 tablets.Dispense in a well-closed container as defined in the USP, with a child-resistant closure (as required).Keep tightly closed.Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].Manufactured In Israel By:Diflunisal tablets USP are supplied as follows:500 mg – light blue-purple, capsule-shaped, film-coated tablets, debossed “755/93” on one side, plain on other. Packaged in bottles of 10, 15, 20 and 30 tablets.Dispense in a well-closed container as defined in the USP, with a child-resistant closure (as required).Keep tightly closed.Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].Manufactured In Israel By:Diflunisal tablets USP are supplied as follows:500 mg – light blue-purple, capsule-shaped, film-coated tablets, debossed “755/93” on one side, plain on other. Packaged in bottles of 10, 15, 20 and 30 tablets.Dispense in a well-closed container as defined in the USP, with a child-resistant closure (as required).Keep tightly closed.Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].Manufactured In Israel By:Diflunisal tablets USP are supplied as follows:500 mg – light blue-purple, capsule-shaped, film-coated tablets, debossed “755/93” on one side, plain on other. Packaged in bottles of 10, 15, 20 and 30 tablets.Dispense in a well-closed container as defined in the USP, with a child-resistant closure (as required).Keep tightly closed.Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].Manufactured In Israel By:Diflunisal tablets USP are supplied as follows:500 mg – light blue-purple, capsule-shaped, film-coated tablets, debossed “755/93” on one side, plain on other. Packaged in bottles of 10, 15, 20 and 30 tablets.Dispense in a well-closed container as defined in the USP, with a child-resistant closure (as required).Keep tightly closed.Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].Manufactured In Israel By:Diflunisal tablets USP are supplied as follows:500 mg – light blue-purple, capsule-shaped, film-coated tablets, debossed “755/93” on one side, plain on other. Packaged in bottles of 10, 15, 20 and 30 tablets.Dispense in a well-closed container as defined in the USP, with a child-resistant closure (as required).Keep tightly closed.Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].Manufactured In Israel By:


×

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

Technetium (99mTc) tetrofosmin is a lipophilic, cationic complex which diffuses passively through the cell membrane and is locally retained actively due to the presence of intact mitochondria reflecting the presence of viable cells. After intravenous injection, it is distributed within the myocardium according to myocardial perfusion and viability.

Non-Clinical Toxicology
None.

Patients evaluated with exercise or pharmacologic stress may experience serious adverse reactions such as myocardial infarction, arrhythmia, hypotension, bronchoconstriction, and cerebrovascular reactions such as headache, paraesthesias, convulsions, somnolence and cerebrovascular accident, including hemorrhage. Perform stress testing in the setting where cardiac resuscitation equipment and trained staff are readily available. When pharmacologic stress is selected as an alternative to exercise, perform the procedure in accordance with the pharmacologic stress agent's prescribing information.

The following clinically significant adverse reactions are described elsewhere in the labeling:

×

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

×

Review

Rate this treatment and share your opinion


Learn about User Reviews

Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

Effectiveness (required)

This medication has worked for me.




Ease of Use (required)

This medication has been easy for me to use.




Satisfaction (required)

Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
×

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
×

Tips

Tips

×

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).